Swiss Medical Weekly
The Swiss Medical Weekly is a peer-reviewed open access medical journal published by the SMW supporting association. It was established in 1871 as the Correspondenz-Blatt für Schweizer Aerzte, then renamed to Schweizerische Medizinische Wochenschrift, before obtaining its current title in 2001. SMW was one of the first journals to adhere to the principles of Diamond open access (also known as Platinum Open Access). The editors-in-chief are Adriano Aguzzi and Gérard Waeber.
| Discipline | Medicine |
|---|---|
| Language | English |
| Edited by | Adriano Aguzzi and Gérard Waeber |
| Publication details | |
Former name(s) | Correspondenz-Blatt für Schweizer Aerzte, Schweizerische Medizinische Wochenschrift |
| History | 1871-present |
| Publisher | SMW supporting association |
| Frequency | continuous online |
| 4.203 (2021) | |
| Standard abbreviations | |
| ISO 4 | Swiss Med. Wkly. |
| Indexing | |
| ISSN | 1424-3997 |
| OCLC no. | 807721576 |
| Links | |
Abstracting and indexing
The journal is abstracted and indexed in:
According to the Journal Citation Reports, the journal has a 2021 impact factor of 4.203.[1]
Important papers
In 1957 Roland Kuhn published an observational study on the effectiveness of Imipramine in treating Depression (mood). [2] Other examples are the fundoplication described by Rudolf Nissen[3] in 1956 and the first description of a haemolytic-uraemic syndrome by Conrad Gasser in 1955.[4]
See also
Notes and references
- "Swiss Medical Weekly". 2021 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2021.
- Cahn, Charles (May 2006). "Roland Kuhn, 1912–2005". Neuropsychopharmacology. 31 (5): 1096. doi:10.1038/sj.npp.1301026. ISSN 1740-634X.
- https://pubmed.ncbi.nlm.nih.gov/13337262/
- https://pubmed.ncbi.nlm.nih.gov/13274004/